Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-075626)

Filing Details

Accession Number:: 0001144204-16-075626
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-14 14:11:34
Reporting Period:: 2016-01-13

Filing Date:: 2016-01-14
Accepted Time:: 2016-01-14 14:11:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
910267	Titan Pharmaceuticals Inc	TTNP	Biological Products, (No Disgnostic Substances) (2836)	943171940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190126	R James Mcnab	4 Maguire Road Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-01-13	16,363	$3.16	80,000	No	4	P	Indirect	JR & MW Operating LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	JR & MW Operating LP

Footnotes

Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $3.11 to $3.18. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.